Male Infertility Treatment Market

According to Word Health Organization, ?Infertility is the inability of a sexually active, non-contraception couple to achieve pregnancy in one year?. About 15% of couples do not achieve pregnancy within 1year and seeking for infertility medical treatment. Less than 5% of world population is unwillingly childless. Approximately 90% of male infertility cases are seen mainly due to low sperm counts, and poor sperm quality. The remaining cases of male infertility can be caused by a number of factors including anatomical problems, hormonal imbalances, and genetic defects.
Male Infertility Treatment Market aims to provide a comprehensive presentation of the global market for Male Infertility Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Male Infertility Treatment. Male Infertility Treatment Market contains market size and forecasts of Male Infertility Treatment in global, including the following market information:
Global Male Infertility Treatment Market Revenue, 2018-2023, 20242035, ($ millions)
Global top five companies in 2022 (%)
The global Male Infertility Treatment market was valued at US$ 1341.5 million in 2022 and is projected to reach US$ 2234.4 million by 2029, at a CAGR of 7.6% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
DNA Fragmentation Technique Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Male Infertility Treatment include Merck Serono, Aytu BioScience, Bayer, Cadila, Intas Pharma, Halotech DNA, SCSA diagnostics, Andrology Solutions and Livzon Pharmaceutical Group Inc., etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Male Infertility Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Male Infertility Treatment Market, by Type, 2018-2023, 20242035 ($ millions)
Global Male Infertility Treatment Market Segment Percentages, by Type, 2022 (%)
DNA Fragmentation Technique
Oxidative Stress Analysis
Microscopic Examination
Sperm Agglutination
Computer Assisted Semen Analysis
Sperm Penetration Assay
Global Male Infertility Treatment Market, by Application, 2018-2023, 20242035 ($ millions)
Global Male Infertility Treatment Market Segment Percentages, by Application, 2022 (%)
Hospitals
Clinics
Others
Global Male Infertility Treatment Market, By Region and Country, 2018-2023, 20242035 ($ Millions)
Global Male Infertility Treatment Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Male Infertility Treatment revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Male Infertility Treatment revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Merck Serono
Aytu BioScience
Bayer
Cadila
Intas Pharma
Halotech DNA
SCSA diagnostics
Andrology Solutions
Livzon Pharmaceutical Group Inc.
Zhejiang Xianju Pharmaceutical Co.,Ltd.
GeneScience Pharmaceuticals Co., Ltd.
Abeona Therapeutics Inc.
ASKA Pharmaceutical Co., Ltd.
Bristol Myers Squibb
Church & Dwight
Intas Biopharmaceuticals
Eli Lilly and Company
Outline of Major Chapters:
Chapter 1: Introduces the definition of Male Infertility Treatment, market overview.
Chapter 2: Global Male Infertility Treatment market size in revenue.
Chapter 3: Detailed analysis of Male Infertility Treatment company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Male Infertility Treatment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.